Postsurgical Keytruda Boosts Survival in Clear Cell Renal Cell Carcinoma
Patients with clear cell renal cell carcinoma had improved overall survival when treated with adjuvant Keytruda compared to placebo.
Source: curetoday.com
Data Remains Consistent News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Data Remains Consistent. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Data Remains Consistent Today - Breaking & Trending Today
Adjuvant Pembrolizumab Significantly Prolongs OS vs Placebo in ccRCC
Treatment with adjuvant pembrolizumab significantly improved overall survival vs placebo in patients with clear cell renal cell carcinoma.
Source: onclive.com